Congenital heart disease

Congenital Cardiac Catheterization in Low- and Middle-Income Countries: The International Quality Improvement Collaborative Catheterization Registry

JACC AdvPublished Registry-based descriptive study

Authors' conclusion

This study demonstrates that congenital cardiac catheterization is safely performed in LMICs.

Study context

Population
Congenital heart disease (CHD) cardiac catheterizations in low- and middle-income countries (LMICs), International Quality Improvement Collaborative Congenital Heart Disease Catheterization Registry (IQIC-CHDCR) registry, January 2019–December 2020
Participants
3,287 cases
Outcome
Mortality, severe adverse events (SAEs) and procedural efficacy
Methodological detailsmulticentre, 15 centres
  • Multicentre
  • 15 centres

Main finding

As reported in the abstract

Interventional cases
60% (n = 1,973)
PREDIC3T risk class 1
37%
PREDIC3T risk class 2
38%
Optimal procedure efficacy, PDA device implantation
67%
Optimal procedure efficacy, ASD device implantation
60%

Observational data: associations, not effects.

Further findings

Patient age

Cases in patients aged 1 to 18 years
66%
Median patient age
4 years

Severe adverse events (SAEs) and death

SAEs
2.8%
Death within <72 hours post catheterization
1%

Original publication

Congenital Cardiac Catheterization in Low- and Middle-Income Countries: The International Quality Improvement Collaborative Catheterization Registry. JACC Adv. Published 24 May 2023. doi:10.1016/j.jacadv.2023.100344

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.